MANAGEMENT OF EISENMENGER SYNDROME IN A LATE PRESENTATION OF TRANSPOSITION OF THE GREAT ARTERIES ASSOCIATED WITH INCIDENTAL ADRENAL TUMOR. CASE REPORT

  • M.S.C. HABA “Sf. Spiridon” County Clinical Emergency Hospital Iasi
  • Ecaterina STRIMBEANU “Sf. Spiridon” County Clinical Emergency Hospital Iasi
  • O. MITU “Sf. Spiridon” County Clinical Emergency Hospital Iasi
  • Irina Iuliana COSTACHE “Sf. Spiridon” County Clinical Emergency Hospital Iasi

Abstract

We present the case of a 25-year-old patient with transposition of the great arteries (TGA), ventricular septal defect (VSD), without surgical correction, severe pulmonary hypertension and Eisenmenger syndrome, under vasodilatation therapy with Bosentan and Sildenafil, which presented for hemoptysis, shortness of breath at mild effort, myalgia, headaches and vertigo. Blood test showed important erythrocytosis and thrombocytopenia. CT examination revealed the presence of an adrenal incidentaloma (AI), which was proved to be nonfunctional after hormonal testing. Management of the patient included phlebotomy for the treatment of the hyper viscosity syndrome and recommending the addition of a prostacyclin analogue to the vasodilators scheme. The dimensions of the AI raised the question regarding the need of surgical excision, due to the risk of being an adrenal gland carcinoma. Due to the high risk of general anesthesia in Eisenmenger patients, a multidisciplinary team (endocrinologist, cardiologist, surgeon, and anesthesiologist) decided on a watch and wait strategy regarding the tumor, with regular monitoring.

Author Biographies

M.S.C. HABA, “Sf. Spiridon” County Clinical Emergency Hospital Iasi

Department of Cardiology

Ecaterina STRIMBEANU, “Sf. Spiridon” County Clinical Emergency Hospital Iasi

Department of Cardiology

O. MITU, “Sf. Spiridon” County Clinical Emergency Hospital Iasi

Department of Cardiology
“Grigore T. Popa” University of Medicine and Pharmacy Iasi
Faculty of Medicine
Department of Medical Specialties (I)

Irina Iuliana COSTACHE, “Sf. Spiridon” County Clinical Emergency Hospital Iasi

Department of Cardiology
“Grigore T. Popa” University of Medicine and Pharmacy Iasi
Faculty of Medicine
Department of Medical Specialties (I)

References

1. Ginghina C. Mic tratat de cardiologie. Bucuresti: Editura Academiei Române 2017: 732-735.
2. Liebman J, Cullum L, Belloc NB. Natural history of transposition of the great arteries: anatomy and birth and death characteristics. Circulation 1969; 40(2): 237-262.
3. Gatzoulis MA, Alonso-Gonzalez R, Beghetti M. Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease. European Respiratory Review 2009; 18(113): 154-161.
4. Baumgartner H et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010) The Task Force on the Management of Grown-up Congenital Heart Disease of the Eu-ropean Society of Cardiology (ESC). European Heart Journal 2010; 31(23): 2915-2957.
5. Broberg CS et al. Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease. Journal of the American College of Cardiology 2006; 48(2): 356-365.
6. Oechslin E. Hematological management of the cyanotic adult with congenital heart disease. Interna-tional Journal of Cardiology 2004; 97: 109-115.
7. Dimopoulos K et al. Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension. Circulation 2010; 121(1): 20-25.
8. Singh TP, Rohit M, Grover A, Malhotra S, Vijayvergiya R. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension. American Heart Journal 2006; 151(4): 851-e1.
9. Fernandes SM, Newburger JW, Lang P, Pearson DD. Usefulness of epoprostenol therapy in the se-verely ill adolescent/adult with Eisenmenger physiology. The American Journal of Cardiology 2003; 91(5A): 632-635.
10. Simonneau G et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. American Journal of Respiratory and Critical Care Medicine. 2002; 165(6): 800-804.
11. Simonneau G et al. Selexipag, an oral, selective IP receptor agonist for the treatment of pulmonary arterial hypertension. European Respiratory Journal 2012: erj01375-2011.
12. Kapoor A, Morris T, Rebello R. Guidelines for the management of the incidentally discovered adrenal mass. Canadian Urological Association Journal 2011; 5(4): 241.
13. Solanki SL, Vaishnav V, Vijay AK. Non-cardiac surgery in a patient with Eisenmenger syndrome-anaesthesiologist's challenge. Journal of Anesthesiology, Clinical Pharmacology 2010; 26(4): 539.
14. Bennett JM, Ehrenfeld JM, Markham L, Eagle SS. Anesthetic management and outcomes for patients with pulmonary hypertension and intracardiac shunts and Eisenmenger syndrome: a review of institu-tional experience. Journal of Clinical Anesthesia 2014; 26(4): 286-293.
15. Martin JT, Tautz TJ, Antognini JF. Safety of regional anesthesia in Eisenmenger's syndrome. Regional anesthesia and pain medicine 2002; 27(5): 509-513.
Published
2018-12-27
Section
INTERNAL MEDICINE - PEDIATRICS